Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use Cases
Public ClinicalTrials.gov record NCT02992249. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a prospective uncontrolled observational study to evaluate clinical outcomes following use of the ReCell Autologous Cell Harvesting Device (ReCell) as an adjunct for closure (re-epithelialization) as a treatment of life-threatening wounds requiring grafting for closure, and associated skin graft donor sites, in patients who lack adequate available skin to harvest for conventional grafting. Treatment with the ReCell device may be performed as part of a single operative procedure, or multiple staged procedures as deemed clinically necessary. Adverse events associated with the use of the ReCell device/cell suspension will be documented. Subjects will be followed for 1 year following ReCell treatment.
Study identification
- NCT ID
- NCT02992249
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2014 (Type not available)
- Primary completion
- May 2019 (Actual)
- Completion
- Jun 2020 (Actual)
- Last update posted
- Aug 3, 2020
2014 – 2020
United States locations
- U.S. sites
- 22
- U.S. states
- 16
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama Department of Surgery | Mobile | Alabama | 36688 | — |
| Arizona Burn Center at Maricopa Integrated Health Systems | Phoenix | Arizona | 85008 | — |
| University of California San Diego Regional Burn Center | San Diego | California | 92103-8896 | — |
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Grady Memorial Hospital | Atlanta | Georgia | 30303 | — |
| Joseph M Still Research Foundation | Augusta | Georgia | 30909 | — |
| Richard M. Fairbanks Burn Center at Eskenazi Health | Indianapolis | Indiana | 46202 | — |
| Baton Rouge General Regional Burn Center | Baton Rouge | Louisiana | 70809 | — |
| University Medical Center | New Orleans | Louisiana | 70112 | — |
| Maine Medical Center | Portland | Maine | 04102 | — |
| Walter Reed National Military Medical Center Bethesda | Bethesda | Maryland | 20889 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Shriner's Boston | Boston | Massachusetts | 02114 | — |
| MS Burn & Reconstruction Center, Merit Health Central | Jackson | Mississippi | 39204 | — |
| University of Missouri Health Care | Columbia | Missouri | 65212 | — |
| Children's Mercy Kansas City | Kansas City | Missouri | 64108 | — |
| Mercy General Burn Center - Springfield | Springfield | Missouri | 65804 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | — |
| St. Christopher's Hospital for Children | Philadelphia | Pennsylvania | 19134 | — |
| University of Tennessee Health Science Center | Memphis | Tennessee | 38103-3409 | — |
| U.S.Army Institute of Surgical Research | Fort Sam Houston | Texas | 78234-7767 | — |
| University of Texas Health Science Center at Houston | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02992249, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 3, 2020 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02992249 live on ClinicalTrials.gov.